Cargando…
High Throughput Screening for Inhibitors of Alpha-Galactosidase
Fabry disease is a rare X-linked lysosomal storage disorder caused by a deficiency in α-galactosidase A (GLA), which catalyzes the hydrolysis of terminal α-galactosyl groups from glycosphingolipids, such as globotriaosylceramide (Gb3). Many of the mutations in the GLA gene are missense alterations t...
Autores principales: | Motabar, Omid, Liu, Ke, Southall, Noel, Marugan, Juan J, Goldin, Ehud, Sidransky, Ellen, Zheng, Wei |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Bentham Open
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3040456/ https://www.ncbi.nlm.nih.gov/pubmed/21331308 http://dx.doi.org/10.2174/1875397301004010067 |
Ejemplares similares
-
High Throughput Screening for Small Molecule Therapy for Gaucher Disease Using Patient Tissue as the Source of Mutant Glucocerebrosidase
por: Goldin, Ehud, et al.
Publicado: (2012) -
Fabry Disease – Current Treatment and New Drug Development
por: Motabar, Omid, et al.
Publicado: (2010) -
A High Throughput Screening Assay System for the Identification of Small Molecule Inhibitors of gsp
por: Bhattacharyya, Nisan, et al.
Publicado: (2014) -
High-Throughput Multiplexed Quantitation of Protein Aggregation and Cytotoxicity in a Huntington’s Disease Model
por: Titus, Steven A, et al.
Publicado: (2012) -
High-throughput screening identified selective inhibitors of exosome biogenesis and secretion: A drug repurposing strategy for advanced cancer
por: Datta, Amrita, et al.
Publicado: (2018)